86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details


臨床試験数 : 1,181 薬物数 : 712 - (DrugBank : 126) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 191

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000001709
2009/02/0116/02/2009Multikinase Inhibitor (Tyrosine and Serine/Threonine Kinase Inhibitor) for the Treatment of Severe Pulmonary Arterial Hypertension pulmonary arterial hypertensionadministration of sorafenib, which is the multikinase inhibitor (tyrosine and serine/threonine kinase inhibitor)Medical Education Center, School of Medicine, Keio UniversityNULLPending20years-oldNot applicableMale and Female10Not selectedJapan
2NCT00452218
(ClinicalTrials.gov)
March 200726/3/2007Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial HypertensionDrug: SorafenibUniversity of ChicagoBayerCompleted18 YearsN/ABoth12Phase 1United States